Cambridge Innovation Capital — Full Portfolio

Deeptech Labs is a seed-stage venture capital firm and accelerator focused on deep technology companies founded with the University of Cambridge and industry partners including Arm and Cambridge Innovation Capital.

AI & Machine LearningDeep TechCambridge, GB

MKMiles Kirby(Chief Executive Officer)in

BoardEwan Kirk(Investor and Chair)

Co-investorsARARMEMEMV Capital

Imagen builds a video management platform designed to help clients make video content measurable, manageable, and profitable.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareMedia & EntertainmentSaaSLondon, GB

Anthony BlakePaul McConkey

Co-investorsGUGuinness VenturesWOWormhole CapitalCACadenzaHAHaystackMEMenlo VenturesNFNFX+2 more

Immutrin is a biotechnology company developing antibody therapies designed to remove systemic amyloid deposits and reverse amyloidosis.

BiotechMedical Devices

MPMark Pepys(Co-founder; Emeritus Professor of Medicine at UCL)GWGregory Winter(Co-founder; Nobel Laureate)DCDaniel Christ(Co-founder; Professor, Faculty of Medicine, UNSW)

Co-investorsFRFrazier Life SciencesQIQiming Venture PartnersF-F-Prime CapitalSRSR One Capital Management

Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.

CleantechDeep TechHardwareSemiconductorsCambridge, GB

SWScott WhiteinRPRichard Pricein

Co-investorsINIn-Q-TelPRProsperity7 VenturesARARMBRBritish Patient CapitalCACatalystNONorth East Development Capital Fund+4 more

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.

BiotechDeep TechHealthtechMedical Devices

MMMichal Minczuk(Co-Founder)inGMGabriel Martinez(Chief Scientific Officer & Co-Founder)CGClaes Gustafsson(Co-Founder)MFMaria Falkenberg(Co-Founder)NLNils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)

Co-investorsARARCH Venture PartnersEIEIR VenturesANAngelini VenturesGVGV (Google Ventures)HEHealthCapINInvus+2 more

Secondmind provides AI-powered software to help automotive engineers accelerate vehicle design and development.

AI & Machine LearningDeep TechSaaSCambridge, GB

CECarl Edward Rasmussen(Chief Science Officer)inGBGary Brotman(Chief Executive Officer & Founder)in

Co-investorsAMAmadeus Capital PartnersATAtlantic Bridge VenturesPAPassion CapitalREReefknot InvestmentsSISingapore Innovate Pte. Ltd.

TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.

BiotechDeep TechLongevityMedical DevicesCambridge, GB

Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)

Co-investorsPFPfizer VenturesSVSV Health InvestorsM M VenturesPFPfizer Venture InvestmentsSTStart CodonDIDiamond Edge Ventures

BiotechCambridge

Jeffrey Buchalter(Director)Clive Morris(Executive Officer, Director)Peter Wright-Smith(Director)Douglas M. VanOrt(Director)Timothy Shannon(Executive Officer)

Board seatRTRobert Tansley· per SEC Form D

Co-investorsFUFuture Planet CapitalRORosetta Capital Ltd.

52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.

BiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsMEMeridian Health VenturesCACambridge Angels groupFUFuture Planet CapitalPAParkwalk AdvisorsSISie VenturesCRCrista Galli Ventures+2 more

Disruptive hearing/audio clarity technology start-up

Co-investorsOCOctopus VenturesPAParkwalk Advisors

BehavioSec provides behavioral biometrics and analytics that silently collect device and behavioral signals to detect fraud, verify identity, and generate risk scores in near real time.

AI & Machine LearningCybersecurityFintechInsurTechPalo Alto, US

NCNeil Costigan(Founder)inOROlov Renberg(Founder)inKristofer Nyberg(Founder)Kristofer Nygren(Founder)Peder Nordström(Founder)

BoardJosh Pouliot(Director)

Co-investorsCICisco InvestmentsFOForgePoint CapitalNONorthzoneOCOctopus VenturesNINightDragon

BeyondMath develops a foundational AI model trained on physics principles that enables generative design across industries.

AI & Machine LearningDeep TechEnterprise Software

AlanDarren

Co-investorsINInMotion VenturesUPUP PartnersCRCreator FundINInsight Partners

Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.

CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB

FNFabio Necco(CEO)in

Co-investorsEMEMV CapitalIQIQ CapitalMAMartlet CapitalBRBritish Patient CapitalBUBusiness Growth FundEPePlanet Capital+1 more

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

TPTimothy Pearson(CEO)ABAsh Bahl(CSO)inJHJenny Horsfield(CBO)inSMStuart McIntosh(CMO)inDSDavid Sutherland(VP Finance & Controller)

Co-investorsARARCH Venture PartnersB B Capital GroupB4B4 CapitalGVGV (Google Ventures)LILightstone VenturesRERevelation Partners+2 more

Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders.

BiotechHealthtech

Co-investorsADAdvent Life SciencesECEcoR1 CapitalFOForesite CapitalGEGeneral AtlanticLILifeSci Venture PartnersMEMedicxi+4 more

CMR Surgical develops Versius, a small, modular, and portable surgical robot that enables hospitals and surgeons to perform minimal access (keyhole) surgery.

HealthtechMedical DevicesRobotics

MCMassimillano Colella(Chief Executive Officer)

Co-investorsLILightrockSASandwaterSOSoftBank Vision FundWAWatrium

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

RHRafiq Hasan(CEO and Managing Director)inMAMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsBIBioGeneration VenturesGIGimvHAHadean VenturesSESeroba Life SciencesBGBGVFOForbion+2 more

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsFUFuture Planet CapitalQVQVenturesXEXeraya CapitalAMAmadeus Capital PartnersIDIDO InvestmentsLELegal & General+3 more

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.

BiotechDeep TechNew MaterialsCambridge, GB

JCJason Chin(Professor)Jason W. Chin(Founder)Julius Fredens(Founder)Ola Wlodek, PhD(CEO)Prof. Jason Chin, PhD(CSO & Founder)

Co-investors+N+ND CapitalAMAmadeus Capital PartnersFIFine Structures VenturesGEGENERAL INCEPTIONLOLongeVCOMOMX Ventures+2 more

Cytora provides AI-powered risk processing software for commercial insurance carriers and brokers to automate underwriting, claims decisions, and portfolio management.

AI & Machine LearningEnterprise SoftwareInsurTech

RHRichard Hartley(Founder)inAWAeneas Wiener(Founder)inAndre Alzamora(Founder)Joshua Wallace(Founder)

Co-investorsEQEQT VenturesCLClaret Capital PartnersPAParkwalk AdvisorsQBQBE Ventures

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

CPClaude PerreaultPTPierre Thibault

Co-investorsADAdvent Life SciencesCTCTI Life Sciences Fund L.P.ADadMare BioInnovationsFOFonds de solidarité FTQ

Exciting Instruments builds the EI-FLEX benchtop platform, a single-molecule fluorescence instrument combining smFRET, FCS and FCCS to measure biomolecular interactions and dynamics directly in solution.

BiotechDeep TechHardware

Timothy Craggs(Founder and CEO)

Co-investorsNONorthern GritstoneEMEmpirical VenturesPRPraetura Ventures

Fluidic Sciences develops in-solution technologies and instruments for protein interaction analysis, enabling researchers to measure how proteins interact without immobilization complexities.

AI & Machine LearningBiotechDeep TechHardware

JWJames Wilkinson(Chief Executive Officer)in

BoardMark Gilligan(Chairman)

Co-investorsHEHeran PartnersDRDraper Esprit

Forefront RF develops tunable RF duplexer technology for mobile and cellular devices, replacing multiple fixed RF components with a single adaptive, software-defined solution.

Deep TechHardwareSemiconductors

Co-investorsCACambridge Angels groupOCOctopus VenturesEPePlanet Capital

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOxford, GB

Co-investorsMAMaven Capital Partners

GeoSpock developed a cloud-based spatial big-data platform (GeoSpock DB) that fused and analyzed large volumes of geospatial and IoT sensor data for applications like smart cities and connected vehicles.

Data & InfrastructureFintechCambridge, GB

Co-investorsGLGlobal BrainTETechstars

Novartis is a pharmaceutical company that develops and commercializes prescription medicines and therapies across therapeutic areas including oncology, cardiovascular disease, and immunology.

BiotechMedical Devices

Co-investorsSOSofinnova Ventures

Imagen builds diagnostic imaging technology that combines clinical expertise and advanced technology to deliver consistent high-quality diagnostic care across healthcare sites.

AI & Machine LearningHealthtechMedical Devices

Alex Dresner(Founder)Rob Lindsey(Founder)Sumit Chopra(Founder)Tom Hotchkiss(Founder)

Co-investorsGVGV (Google Ventures)KLKli CapitalSUSummit PartnersTETeamworthy VenturesTHThreshold VenturesNENexus Venture Partners+1 more

Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease.

BiotechDigital HealthHealthtechMedical DevicesCambridge, GB

TLTrevor Lawley(Co-founder and CSO)in

Co-investorsSESeventure PartnersDCDCVC (Data Collective)IPIP Group

A biopharmaceutical company operating in early drug development, commercialization, and life cycle management within the therapeutics and life sciences industry.

Biotech

Nuclera provides multiplex protein screening technology for life science researchers, enabling faster access to and testing of proteins for drug discovery and development.

AI & Machine LearningBiotechDeep TechHardwareCambridge, US

Co-investorsBRBritish Business BankAMAmadeus Capital PartnersFUFuture Planet Capital

Origami is an AI-powered platform that helps sales teams identify and enrich prospective customers through intelligent prospecting and signal-based lead generation.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US

FMFinn Mallery(CEO)inKCKenson Chung(CTO)inLuke Clancy(Founder)

Co-investorsY Y CombinatorAPAppWorks VenturesOCOctopus VenturesVAValor Capital GroupGLGlobal BrainPEPeterson Venture Partners+4 more

Novel antibody-based therapeutics platform for animal health.

Co-investorsCOCompanion FundDIDigitalis VenturesPAParkwalk AdvisorsVCVCapital

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.

AI & Machine LearningHealthtechMedical Devices

Co-investorsADAdara VenturesAMAmadeus Capital PartnersAPAPEX VenturesASAsabys PartnersLILifeX VenturesPAPartech Ventures+5 more

Riverlane builds quantum error correction hardware and software, including its Deltaflow real-time QEC system, for quantum computer makers.

Cambridge, GB

SBSteve Brierley(Founder)in

Co-investorsAMAmadeus Capital PartnersETETF PartnersMOMolten VenturesALAltaIR CapitalUNUniversity of Cambridge Enterprise

Spin-out from the Universities of Oxford and Munster developing a novel semiconductor chip.

VKVaysh Kewada(Founder)in

Co-investorsBOBorski FundOXOxford Science EnterprisesPEPerivoli InnovationsSISilicon CatalystAPApplied VenturesDEDeeptech Labs

Johannes Feldmann(Founder)Vaysh Kewada(Founder)

Co-investorsBOBorski Fund

Seldon provides a Kubernetes-native MLOps and LLMOps platform for deploying, scaling, and governing machine learning and AI models in production across any cloud or on-premise environment.

AI & Machine LearningCloud ComputingDeveloper ToolsLondon, GB

Co-investorsALAlbionVCAMAmadeus Capital PartnersBRBright Pixel CapitalGLGlobal BrainTETechstarsTHThundermark Capital+1 more

Shift Bioscience develops siRNA therapeutics for cell rejuvenation, using a target identification platform that has identified an anti-fibrotic candidate initially aimed at liver fibrosis.

AI & Machine LearningBiotechLongevityCambridge, GB

DIDaniel Ives(Founder & CEO)inBSBrendan Swain(Co-founder & CSO)in

Co-investorsF-F-Prime CapitalIKIKJ CapitalKIKindred Capital

Sortera Bio develops biotechnology solutions, with a team of scientists and engineers specializing in microfluidics, software, and platform operations.

AI & Machine LearningBiotechDeep Tech

Ben Porebski(CEO-CTO, Founder)Philipp Holliger(Founder)

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical Devices

Co-investorsFAFast Track InitiativeM M VenturesPFPfizer Venture InvestmentsSESeroba Life SciencesTATaiho Ventures, LLCUTUTokyo Innovation Platform Co. Ltd.+3 more

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsF-F-Prime CapitalSASanofi VenturesSOSofinnova PartnersBUBusiness Growth FundDIDigitalis VenturesUNUniversity of Cambridge Enterprise

Trent is an AI security engineer that maps an organization's software, services, and AI agents to reveal the real attack surface, triages vulnerabilities from existing security tools down to what is exploitable, and generates remediation recommendations with a full audit trail.

AI & Machine LearningCybersecurityEnterprise SoftwareGent, BE

Neil Lawrence(Founder)in

Co-investorsLOLocalGlobe

UnlikelyAI builds AI technology designed to support real-world decision-making through interpretable and trustworthy models.

AI & Machine LearningEnterprise Software

Co-investorsAMAmadeus Capital PartnersCACambridge Angels groupMEMetaplanetMSMS&AD VenturesOCOctopus Ventures